4.7 Article

Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Predicting new molecular targets for known drugs

Michael J. Keiser et al.

NATURE (2009)

Article Infectious Diseases

Antileishmanial activity of nano-amphotericin B deoxycholate

Krishna Das Manandhar et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)

Article Multidisciplinary Sciences

Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development

Antonio Cavazzuti et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Medicine, General & Internal

Injectable paromomycin for visceral leishmaniasis in India

Shyam Sundar et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Review Parasitology

Comparative genomics: From genotype to disease phenotype in the leishmaniases

Deborah F. Smith et al.

INTERNATIONAL JOURNAL FOR PARASITOLOGY (2007)

Review Immunology

Immunopathogenesis of infection with the visceralizing Leishmania species

ME Wilson et al.

MICROBIAL PATHOGENESIS (2005)

Article Biotechnology & Applied Microbiology

Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

BL Roth et al.

NATURE REVIEWS DRUG DISCOVERY (2004)

Article Immunology

Novel mechanism of drug resistance in kala azar field isolates

N Singh et al.

JOURNAL OF INFECTIOUS DISEASES (2003)

Article Biochemistry & Molecular Biology

Pteridine reductase mechanism correlates pterin metabolism with drug resistance in trypanosomatid parasites

DG Gourley et al.

NATURE STRUCTURAL BIOLOGY (2001)

Review Chemistry, Medicinal

Biologically active dihydropyrimidones of the Biginelli-type - a literature survey

CO Kappe

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2000)